References
- Young R.R., Delwaide P.J. Spasticity (second of two parts). N. Engl. J. Med. 1981; 304: 96–99
- Chen K.S., Bullard M.J., Chien Y.Y., Lee S.Y. Baclofen toxicity in patients with severely impaired renal function. Ann. Pharmacother. 1997; 31: 1315–1320
- Choo Y.M., Kim G.B., Choi J.Y., Park J.H., Yang C.W., Kim Y.S., Bang B.K. Severe respiratory depression by low-dose baclofen in the treatment of chronic hiccups in a patient undergoing CAPD. Nephron Dec, 2000; 86(4)546–547
- Himmelsbach F.A., Kohler E., Zanker B., Wandel E., Kramer G., Poralla T. Toxic effect of baclofen in chronic haemodialysis and renal transplantation. Dtsch. Med. Wochenschr. 1992; 117: 733–737
- Seyfert S., Kraft D., Wagner K. Baclofen toxicity during intermittent dialysis. Nervenarzt. 1981; 52: 616–617
- Lee T.H., Chen S.S., Su S.L., Yang S.S. Baclofen intoxication: report of four cases and review of the literature. Clin. Neuropharmacol. 1992; 15: 56–62
- Peces R., Navascues R.A., Baltar J., Laures A.S., Alvarez-Grande J. Baclofen neurotoxicity in chronic haemodialysis patients with hiccups. Nephrol. Dial. Transplant. 1998; 13: 1896–1897
- Bassilios N., Launay-Vacher V., Mercadal L., Deray G. Baclofen neurotoxicity in a chronic haemodialysis patient. Nephrol. Dial. Transplant. 2000; 15: 715–716
- Perez del Molino A., Sampedro I., Gonzalez Macias J. Tratamiento del hipo intratable con baclofen. Rev. Clin. Esp. 1996; 196: 831–833
- Fromm G.H., Terrence C.F., Chattha A.S. Baclofen in the treatment of refractory trigeminal neuralgia. Neurology 1979; 29: 550–551
- Sandyk R. Baclofen in hemifacial spasm. Eur. Neurol. 1984; 23: 163–165
- Glazer W.M., Moore D.C., Bowers M.B. The treatment of tardive dyskinesia with baclofen. Psychopharmacology 1985; 87: 480–483
- Eriksson G., Swahn C.G. Concentrations of baclofen in serum and breast milk from a lactating woman. Scand. J. Clin. Lab. Invest. 1981; 41: 185–187
- Anderson P., Noher H., Swahn C.G. Pharmacokinetics in baclofen overdose. Clin. Toxicol. 1984; 22: 11–20
- Knutsson E., Lindblom U.L.F., Martensson A. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis. J. Neurol. Sci. 1974; 23: 473–484
- Faigle J.W., Keberle H. The chemistry and kinetics of Lioresal. Postgrad. Med. J. 1972; 48(Oct Suppl.)9–13
- Wuis E.W., Dirks M.J., Termond E.F., Vree T.B., Van der Kleijn E. Plasma and urinary excretion kinetics of oral baclofen in healthy subjects. Eur. J. Clin. Pharmacol. 1989; 37: 181–184
- White W.B. Aggravated CNS depression with urinary retention secondary to baclofen administration. Arch. Intern. Med. 1985; 145: 1717–1718
- Hulme A., MacLennan W.J., Ritchie R.T., John V.A., Shotton P.A. Baclofen in the elderly stroke patient: its side effects and pharmacokinetics. Eur. J. Clin. Pharmacol. 1985; 29: 467–469